Autolus Therapeutics (NASDAQ:AUTL – Free Report) had its price target raised by Needham & Company LLC from $7.00 to $8.00 in a research note published on Monday, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. Several other research firms have also weighed in on AUTL. Deutsche Bank Aktiengesellschaft assumed […]
Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) traded up 9.2% during trading on Wednesday . The company traded as high as $6.03 and last traded at $6.03. 941,714 shares traded hands during mid-day trading, a decline of 29% from the average session volume of 1,322,428 shares. The stock had previously closed at $5.52. Wall […]
Autolus Therapeutics (NASDAQ:AUTL – Get Free Report) had its price target hoisted by analysts at Needham & Company LLC from $7.00 to $8.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s target price would suggest a potential upside of 35.14% from […]
Autolus Therapeutics (NASDAQ:AUTL – Free Report) had its price target increased by The Goldman Sachs Group from $3.20 to $4.80 in a report issued on Wednesday, Benzinga reports. The firm currently has a neutral rating on the stock. Other research analysts have also issued research reports about the stock. Deutsche Bank Aktiengesellschaft started coverage on […]
Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) reached a new 52-week high during trading on Thursday after The Goldman Sachs Group raised their price target on the stock from $3.20 to $4.80. The Goldman Sachs Group currently has a neutral rating on the stock. Autolus Therapeutics traded as high as $5.00 and […]